Clinical and Economic Value of Reducing Antimicrobial Resistance in the Management of Hospital-Acquired Infections with Limited Treatment Options in Greece.
Myrto BarmpouniJason P GordonRyan L MillerJames W DennisVassilis GrammelisAris RousakisKyriakos SouliotisGaryphallia PoulakouGeorge L DaikosAmer Al TaiePublished in: Infectious diseases and therapy (2023)
This study shows the substantial clinical and economic burden AMR represents to the Greek healthcare system and the value that can be achieved by effectively reducing AMR levels.